Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src/PI3K/Akt pathway

Tamoxifen (TAM) resistance has indicated a significant challenge during endocrine therapy for hormone-sensitive breast cancer. Thus, it is significant to elucidate the molecular events endowing TAM resistance to endocrine therapy. In this study, we found that epithelial-mesenchymal transition (EMT)...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int J Biol Sci
Päätekijät: Wu, Deng-Pan, Zhou, Yan, Hou, Li-Xiang, Zhu, Xiao-Xiao, Yi, Wen, Yang, Si-Man, Lin, Tian-Yu, Huang, Jin-Lan, Zhang, Bei, Yin, Xiao-Xing
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Ivyspring International Publisher 2021
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8315014/
https://ncbi.nlm.nih.gov/pubmed/34326682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijbs.55453
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia